By Dr Samuel Seidu2018-11-09T12:16:00+00:00
Dr Samuel Seidu answers questions on the impact of type 2 diabetes on patients’ daily lives, differences between NICE and SIGN guidance, and key take-home messages for primary care.
This was an independent session organised by MGP without financial support or involvement from the pharmaceutical industry.
Covering the infection prevention and control principles required to prevent transmission of COVID-19 and other respiratory viruses for winter 2021–2022
In updated guidance on therapeutics for COVID-19, the World Health Organization has added recommendations on two new drugs to treat the disease
Potentially active coronavirus may persist beyond 10 days, facilitating onward transmission of COVID-19 after a person has completed the advised quarantine period
This session was supported by an educational grant from Mylan Ltd. Dr Glenis Scadding comments on the main presentations of rhinitis, its impact on patients’ daily lives, red flags for referral, and the main recommendations of the 2017 BSACI guideline
Dr Kevin Fernando answers questions on the impact of type 2 diabetes on patients’ daily lives, differences between NICE and SIGN guidance, and key take-home messages for primary care
Dr Matt Fay, Chair of Guidelines Live 2018, provides his thoughts on the programme from a primary care perspective, and summarises the meetings.
Site powered by Webvision Cloud